Bayer UK launches new CanesMeno Educational Hub and product range to transform menopause support: Leverkusen Friday, January ...

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report fourth-quarter and full-year 2024 results on Feb. 4, 2025. The Zacks Consensus Estimate for fourth-quarter revenues is pegged at ...

In this webinar, sponsored by IPG Health, we will explore the role that cell and gene therapies can play in treating rare diseases, the unique challenges faced by pharmaceutical companies, healthcare ...

Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...

Iberdrola has signed power purchase agreements (PPAs) totalling 1,251 MW in 2024, a 38% increase compared to 2023. In Iberia, agreements were reached with Alcampo (Auchan), Burger King, BP, and ...

The fight for dominance between Regeneron and Bayer’s big blockbuster eye drug Eylea and Roche’s rival Vabysmo is playing out ...

Donald Trump’s inaugural committee was funded by Amazon, Chevron, Coinbase, Coca-Cola, Comcast, ExxonMobil, GEO Group, ...

The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...

Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts ...

The American CEO of Swiss drugmaker Novartis on Friday warned that the United States' exit from the World Health Organization ...

The Global Smart Agriculture Market Size is projected to grow at a CAGR of 10.30% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...